FDA to review OTC Narcan spray
The overdose treatment could be more widely available in spring
By Leila Merrill
GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced this month that the FDA accepted for review its supplemental new drug application for Narcan nasal spray as an over-the-counter emergency treatment.
The overdose treatment could become available over the counter as soon as March 29.
"We are taking to this step to help address the rising and devastating number of opioid overdoses and fatalities happening across the country," Emergent CEO Robert Kramer said in a statement.